Krembil Research Institute, Fundamental Neurobiology, Toronto, ON M5T 2S8, Canada.
Sunnybrook Research Institute, Medical Biophysics, Toronto, ON M4N 3M5, Canada.
Int J Mol Sci. 2017 Oct 28;18(11):2269. doi: 10.3390/ijms18112269.
Epilepsy afflicts up to 1.6% of the population and the mechanisms underlying the appearance of seizures are still not understood. In past years, many efforts have been spent trying to understand the mechanisms underlying the excessive and synchronous firing of neurons. Traditionally, attention was pointed towards synaptic (dys)function and extracellular ionic species (dys)regulation. Recently, novel clinical and preclinical studies explored the role of brain metabolism (i.e., glucose utilization) of seizures pathophysiology revealing (in most cases) reduced metabolism in the inter-ictal period and increased metabolism in the seconds preceding and during the appearance of seizures. In the present review, we summarize the clinical and preclinical observations showing metabolic dysregulation during epileptogenesis, seizure initiation, and termination, and in the inter-ictal period. Recent preclinical studies have shown that 2-Deoxyglucose (2-DG, a glycolysis blocker) is a novel therapeutic approach to reduce seizures. Furthermore, we present initial evidence for the effectiveness of 2-DG in arresting 4-Aminopyridine induced neocortical seizures in vivo in the mouse.
癫痫影响着高达 1.6%的人口,但其发病机制仍未被完全理解。在过去的几年中,人们付出了很多努力来试图理解神经元过度同步放电的机制。传统上,人们关注的是突触(功能)障碍和细胞外离子种类(功能)调节。最近,新的临床和临床前研究探讨了脑代谢(即葡萄糖利用)在癫痫发病生理学中的作用,揭示了(在大多数情况下)发作间期代谢降低和发作前和发作期间代谢增加。在本综述中,我们总结了在癫痫发生、发作起始和终止以及发作间期期间代谢失调的临床和临床前观察结果。最近的临床前研究表明,2-脱氧葡萄糖(2-DG,一种糖酵解抑制剂)是一种减少癫痫发作的新的治疗方法。此外,我们还提供了初步证据,证明 2-DG 在体内阻止 4-氨基吡啶诱导的小鼠新皮层癫痫发作的有效性。